Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$592,612
-$42,241 QoQ
Shares Held
2,355
-19.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,016
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $5,321,402 across 15 Drug Manufacturers - General names. ABBV ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,905 | $2,261,602 | |
| 2 | LLY |
ELI LILLY & Co
|
839 | $1,006,321 | |
| 3 | AMGN |
Amgen Inc
|
2,109 | $763,711 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,355 | $592,612 | |
| 5 | PFE |
Pfizer Inc
|
11,175 | $269,094 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,290 | $165,765 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,848 | $106,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
677 | $85,532 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $592,612 | 2,355 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $634,853 | 2,919 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $802,913 | 3,514 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $542,961 | 2,345 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $477,785 | 2,574 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $481,057 | 2,296 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $578,058 | 3,253 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,266,675 | 11,478 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,963,560 | 11,448 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,065,014 | 11,340 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,977,107 | 12,758 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,872,044 | 12,559 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,731,415 | 12,851 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,040,573 | 12,804 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,174,300 | 13,454 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,933,966 | 14,410 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,119,428 | 13,838 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,509,138 | 15,478 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,454,395 | 18,127 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,083,832 | 19,318 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,666,396 | 14,794 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,577,739 | 14,579 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,630,930 | 15,221 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,063,167 | 12,138 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,126,026 | 11,469 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $815,766 | 10,707 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||